Petco Health & Wellness (NASDAQ: WOOF) financial statements
The consolidated income statement, balance sheet and cash flow statement of Petco Health & Wellness for its last 6 fiscal years, as filed with the regulator, in millions of US dollars. At the end of fiscal 2026 it had $5,173m in total assets and $1,164m in equity.
Income statement
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $5,961m | $6,116m | $6,255m | $6,036m | $5,807m | $4,920m |
| Cost of sales | $3,656m | $3,792m | $3,901m | $3,609m | $3,381m | $2,813m |
| Gross profit | $2,305m | $2,324m | $2,354m | $2,427m | $2,427m | $2,107m |
| Operating profit | $120.4m | $7.1m | −$1,180m | $225.6m | $266.1m | $194.4m |
| Finance costs | $131.2m | $143.5m | $150.9m | $101.6m | $77.4m | $219.1m |
| Profit before tax | $15.3m | −$109.3m | −$1,308m | $112.3m | $202.4m | −$41.6m |
| Income tax | $6.3m | $7.5m | $27.6m | $35.3m | $53.5m | $3.3m |
| Net profit | $9.1m | −$101.8m | −$1,280m | $90.8m | $164.4m | −$26.5m |
| Earnings per share | $0.03 | −$0.37 | −$4.78 | $0.34 | $0.62 | −$0.13 |
| Diluted earnings per share | $0.03 | −$0.37 | −$4.78 | $0.34 | $0.62 | −$0.13 |
| Depreciation and amortisation | $196.7m | $208.5m | $203.6m | $193.8m | $172.4m | $174.8m |
Balance sheet
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Total assets | $5,173m | $5,194m | $5,363m | $6,613m | $6,498m | $6,076m |
| Current assets | $1,020m | $973.6m | $951.7m | $1,016m | $1,071m | $777.5m |
| Inventories | $590.2m | $653.3m | $684.5m | $652.4m | $675.1m | $538.7m |
| Property, plant and equipment | $656.1m | $725.4m | $816.4m | $803.3m | $726.9m | $627.5m |
| Goodwill | $980.1m | $980.1m | $980.3m | $2,194m | $2,184m | $2,179m |
| Cash | $256.7m | $165.8m | $125.4m | $201.9m | $211.6m | $111.4m |
| Total liabilities | $4,009m | $4,081m | $4,179m | $4,231m | $4,242m | $4,020m |
| Current liabilities | $1,134m | $1,139m | $1,113m | $1,021m | $1,053m | $875.3m |
| Equity | $1,164m | $1,114m | $1,184m | $2,381m | $2,274m | $2,069m |
| Equity including minorities | $1,164m | $1,114m | $1,184m | $2,381m | $2,256m | $2,055m |
| Minority interests | $0.0m | $0.0m | $0.0m | $0.0m | −$18.2m | −$13.6m |
Cash flow statement
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $314.1m | $177.7m | $215.7m | $346.0m | $358.2m | $268.6m |
| Investing cash flow | −$124.6m | −$123.9m | −$207.4m | −$320.3m | −$237.1m | −$157.2m |
| Financing cash flow | −$101.7m | −$8.8m | −$85.4m | −$33.8m | −$18.8m | −$146.6m |
| Capital expenditure | −$127.1m | −$128.0m | −$225.6m | −$278.0m | −$239.1m | −$159.6m |
Where each figure comes from
From the annual report (Form 10-K) that Petco Health & Wellness files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021. If an item is not tagged in the filing, it is not in the table. The summary of the last fiscal year is on the Petco Health & Wellness page.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.